|
1
|
Rudwaleit M, van der Heijde D, Landewé R,
Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez
E, Dougados M, et al: The development of Assessment of
SpondyloArthritis international Society classification criteria for
axial spondyloarthritis (part II): Validation and final selection.
Ann Rheum Dis. 68:777–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rudwaleit M, Landewé R, van der Heijde D,
Listing J, Brandt J, Braun J, Burgos-Vargas R, Collantes-Estevez E,
Davis J, Dijkmans B, et al: The development of Assessment of
SpondyloArthritis international Society classification criteria for
axial spondyloarthritis (part I): Classification of paper patients
by expert opinion including uncertainty appraisal. Ann Rheum Dis.
68:770–776. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reveille JD and Arnett FC:
Spondyloarthritis: Update on pathogenesis and management. Am J Med.
118:592–603. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambarus C, Yeremenko N, Tak PP and Baeten
D: Pathogenesis of spondyloarthritis: Autoimmune or
autoinflammatory? Curr Opin Rheumatol. 24:351–358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Long S, Ma L, Wang D and Shang X: High
frequency of circulating follicular helper T cells is correlated
with B cell subtypes in patients with ankylosing spondylitis. Exp
Ther Med. 15:4578–4586. 2008.
|
|
6
|
Xu Z, Wang X and Zheng Y: Screening for
key genes and transcription factors in ankylosing spondylitis by
RNA-Seq. Exp Ther Med. 15:1394–1402. 2018.PubMed/NCBI
|
|
7
|
Wang C, Liao Q, Hu Y and Zhong D: T
lymphocyte subset imbalances in patients contribute to ankylosing
spondylitis. Exp Ther Med. 9:250–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zervou MI, Dimopoulou DG, Eliopoulos E,
Trachana M, Pratsidou-Gkertsi P, Andreou A, Sidiropoulos P,
Spandidos DA, Garyfallos A and Goulielmos GN: Τhe genetics of
juvenile idiopathic arthritis: Searching for new susceptibility
loci. Mol Med Rep. 16:8793–8798. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manasson J, Shen N, Garcia Ferrer HR,
Ubeda C, Iraheta I, Heguy A, Von Feldt JM, Espinoza LR, Garcia
Kutzbach A, Segal LN, et al: Gut microbiota perturbations in
reactive arthritis and postinfectious spondyloarthritis. Arthritis
Rheumatol. 70:242–254. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kabeerdoss J, Sandhya P and Danda D: Gut
inflammation and microbiome in spondyloarthritis. Rheumatol Int.
36:457–468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schaeverbeke T, Truchetet ME and Richez C:
Gut metagenome and spondyloarthritis. Joint Bone Spine. 80:349–352.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmitt SK: Reactive Arthritis. Infect Dis
Clin North Am. 31:265–277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tuuminen T, Lounamo K and Leirisalo-Repo
M: A review of serological tests to assist diagnosis of reactive
arthritis: Critical appraisal on methodologies. Front Immunol.
4:4182013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Girschick HJ, Guilherme L, Inman RD,
Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S and
Doria A: Bacterial triggers and autoimmune rheumatic diseases. Clin
Exp Rheumatol. 26:S12–S17. 2008.PubMed/NCBI
|
|
15
|
Öğrendik M: Oral anaerobic bacteria in the
etiology of ankylosing spondylitis. Clin Med Insights Arthritis
Musculoskelet Disord. 10:11795441177129922017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arvikar SL, Crowley JT, Sulka KB and
Steere AC: Autoimmune arthritides, rheumatoid arthritis, psoriatic
arthritis, or peripheral spondyloarthritis following lyme disease.
Arthritis Rheumatol. 69:194–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lebrun D, Hentzien M, Cuzin L, Rey D, Joly
V, Cotte L, Allavena C, Dellamonica P, Servettaz A and Bani-Sadr F;
the Dat'AIDS study group, : Epidemiology of autoimmune and
inflammatory diseases in a French nationwide HIV cohort. AIDS.
31:2159–2166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Becker J and Winthrop KL: Update on
rheumatic manifestations of infectious diseases. Curr Opin
Rheumatol. 22:72–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vitulano C, Tedeschi V, Paladini F,
Sorrentino R and Fiorillo MT: The interplay between HLA-B27 and
ERAP1/ERAP2 aminopeptidases: From anti-viral protection to
spondyloarthritis. Clin Exp Immunol. 190:281–290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Popa OM, Bojinca M, Bojinca V, Ciofu C,
Dutescu MI, Bardan A, Sfrent-Cornateanu R, Petrek M, Bara C and
Popa L: Distribution of HLA-B27 in Romanian spondyloarthritides
patients. Int J Immunogenet. 37:513–516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Colbert RA, DeLay ML, Klenk EI and
Layh-Schmitt G: From HLA-B27 to spondyloarthritis: A journey
through the ER. Immunol Rev. 233:181–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cherciu M, Popa LO, Bojinca M, Dutescu MI,
Bojinca V, Bara C and Popa OM: Functional variants of ERAP1 gene
are associated with HLA-B27 positive spondyloarthritis. Tissue
Antigens. 82:192–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Popa OM, Kriegova E, Popa L, Schneiderova
P, Dutescu MI, Bojinca M, Bara C and Petrek M: Association study in
Romanians confirms IL23A gene haplotype block rs2066808/rs11171806
as conferring risk to psoriatic arthritis. Cytokine. 63:67–73.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Popa OM, Bojinca M, Bojinca V, Dutescu MI,
Meirosu M, Caisan RE, Ciofu C, Bara C and Popa LO: A pilot study of
the association of tumor necrosis factor alpha polymorphisms with
psoriatic arthritis in the Romanian population. Int J Mol Sci.
12:5052–5059. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Astrauskiene D and Bernotiene E: New
insights into bacterial persistence in reactive arthritis. Clin Exp
Rheumatol. 25:470–479. 2007.PubMed/NCBI
|
|
26
|
Newkirk MM: Antibacterial antibodies and
arthritis: Is there a link? J Clin Rheumatol. 12:1–2. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Clermont O, Bonacorsi S and Bingen E:
Rapid and simple determination of the Escherichia coli phylogenetic
group. Appl Environ Microbiol. 66:4555–4558. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garrett S, Jenkinson T, Kennedy LG,
Whitelock H, Gaisford P and Calin A: A new approach to defining
disease status in ankylosing spondylitis: The Bath Ankylosing
Spondylitis Disease Activity Index. J Rheumatol. 21:2286–2291.
1994.PubMed/NCBI
|
|
29
|
Calin A, Garrett S, Whitelock H, Kennedy
LG, O'Hea J, Mallorie P and Jenkinson T: A new approach to defining
functional ability in ankylosing spondylitis: The development of
the Bath Ankylosing Spondylitis Functional Index. J Rheumatol.
21:2281–2285. 1994.PubMed/NCBI
|
|
30
|
Lukas C, Landewé R, Sieper J, Dougados M,
Davis J, Braun J, van der Linden S and van der Heijde D; Assessment
of SpondyloArthritis international Society, : Development of an
ASAS-endorsed disease activity score (ASDAS) in patients with
ankylosing spondylitis. Ann Rheum Dis. 68:18–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wilbrink B, van der Heijden IM, Schouls
LM, van Embden JD, Hazes JM, Breedveld FC and Tak PP: Detection of
bacterial DNA in joint samples from patients with undifferentiated
arthritis and reactive arthritis, using polymerase chain reaction
with universal 16S ribosomal RNA primers. Arthritis Rheum.
41:535–543. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Clermont O, Christenson JK, Denamur E and
Gordon DM: The Clermont Escherichia coli phylo-typing method
revisited: Improvement of specificity and detection of new
phylo-groups. Environ Microbiol Rep. 5:58–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Santos A, de Andrade Luz L, Napoleão TH,
Paiva PMG and Coelho LCBB: Coaggulation, flocculation,
agglutination and hemagglutination: Similar properties? Adv Chem
Res. 20:51–70. 2014.
|
|
34
|
Herrlinger JD and Asmussen JU: Long term
prognosis in yersinia arthritis: Clinical and serological findings.
Ann Rheum Dis. 51:1332–1334. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sairanen E, Paronen I and Mähönen H:
Reiter's syndrome: A follow-up study. Acta Med Scand. 185:57–63.
1969. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Leirisalo-Repo M: Prognosis, course of
disease, and treatment of the spondyloarthropathies. Rheum Dis Clin
North Am. 24:737–751. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Amor B: Reiter's syndrome: Long-term
follow-up data. Ann Rheum Dis. 38 Suppl 1:S32–S33. 1979. View Article : Google Scholar
|
|
38
|
Ebringer A and Wilson C: HLA molecules,
bacteria and autoimmunity. J Med Microbiol. 49:305–311. 2011.
View Article : Google Scholar
|
|
39
|
Asquith M, Elewaut D, Lin P and Rosenbaum
JT: The role of the gut and microbes in the pathogenesis of
spondyloarthritis. Best Pract Res Clin Rheumatol. 28:687–702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Asquith M and Rosenbaum JT: The
interaction between host genetics and the microbiome in the
pathogenesis of spondyloarthropathies. Curr Opin Rheumatol.
28:405–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hill Gaston JS and Lillicrap MS: Arthritis
associated with enteric infection. Best Pract Res Clin Rheumatol.
17:219–239. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hughes RA and Keat AC: Reiter's syndrome
and reactive arthritis: A current view. Semin Arthritis Rheum.
24:190–210. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wollenhaupt J, Hartmann F, Köhler L,
Kuipers JG, Nettelnbreker E, Frosch M and Zeidler H: Evaluation of
ELISA to detect Chlamydia trachomatis antigen in urine samples from
arthritis patients. Clin Exp Rheumatol. 15:169–174. 1997.PubMed/NCBI
|
|
44
|
Fendler C, Laitko S, Sorensen H,
Gripenberg-Lerche C, Groh A, Uksila J, Granfors K, Braun J and
Sieper J: Frequency of triggering bacteria in patients with
reactive arthritis and undifferentiated oligoarthritis and the
relative importance of the tests used for diagnosis. Ann Rheum Dis.
60:337–343. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Honda K, Iwanaga N, Izumi Y, Tsuji Y,
Kawahara C, Michitsuji T, Higashi S, Kawakami A and Migita K:
Reactive arthritis caused by yersinia enterocolitica enteritis.
Intern Med. 56:1239–1242. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rohekar S, Tsui FW, Tsui HW, Xi N, Riarh
R, Bilotta R and Inman RD: Symptomatic acute reactive arthritis
after an outbreak of salmonella. J Rheumatol. 35:1599–1602.
2008.PubMed/NCBI
|
|
47
|
Simonet ML: Enterobacteria in reactive
arthritis: Yersinia, Shigella, and Salmonella. Rev Rhum Engl Ed.
66:14S–18S; discussion 19S. 1999.PubMed/NCBI
|
|
48
|
Tuompo R, Hannu T, Mattila L, Siitonen A
and Leirisalo-Repo M: Reactive arthritis following Salmonella
infection: A population-based study. Scand J Rheumatol. 42:196–202.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang L, Zhang YJ, Chen J, Huang XL, Fang
GS, Yang LJ, Duan Y and Wang J: The association of HLA-B27 and
Klebsiella pneumoniae in ankylosing spondylitis: A systematic
review. Microb Pathog. 117:49–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rashid T and Ebringer A: Ankylosing
spondylitis is linked to Klebsiella-the evidence. Clin Rheumatol.
26:858–864. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tanimoto Y, Arikawa K and Nishikawa Y:
Effect of diffusely adherent Escherichia coli strains isolated from
diarrhoeal patients and healthy carriers on IL-8 secretion and
tight junction barrier integrity of Caco-2 cells. Vet Immunol
Immunopathol. 152:183–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gill T, Asquith M, Rosenbaum JT and
Colbert RA: The intestinal microbiome in spondyloarthritis. Curr
Opin Rheumatol. 27:319–325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mäki-Ikola O, Hill JL, Lahesmaa R,
Toivanen A and Granfors K: IgG and IgA antibody responses against
porins in Yersinia-triggered reactive arthritis. Br J Rheumatol.
31:315–318. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mäki-Ikola O, Lahesmaa R, Heesemann J,
Merilahti-Palo R, Saario R, Toivanen A and Granfors K:
Yersinia-specific antibodies in serum and synovial fluid in
patients with Yersinia triggered reactive arthritis. Ann Rheum Dis.
53:535–539. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mäki-Ikola O, Pulz M, Heesemann J,
Lahesmaa R, Saario R, Toivanen A and Granfors K: Antibody response
against 26 and 46 kilodalton released proteins of yersinia in
yersinia triggered reactive arthritis. Ann Rheum Dis. 51:1247–1249.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Granfors K, Viljanen M, Tiilikainen A and
Toivanen A: Persistence of IgM, IgG, and IgA antibodies to Yersinia
in yersinia arthritis. J Infect Dis. 141:424–429. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Toivanen A, Lahesmaa-Rantala R, Vuento R
and Granfors K: Association of persisting IgA response with
yersinia triggered reactive arthritis: A study on 104 patients. Ann
Rheum Dis. 46:898–901. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ståhlberg TH, Heesemann J, Granfors K and
Toivanen A: Immunoblot analysis of IgM, IgG, and IgA responses to
plasmid encoded released proteins of Yersinia enterocolitica in
patients with or without yersinia triggered reactive arthritis. Ann
Rheum Dis. 48:577–581. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Toivanen A, Granfors K, Lahesmaa-Rantala
R, Leino R, Ståhlberg T and Vuento R: Pathogenesis of
Yersinia-triggered reactive arthritis: Immunological,
microbiological and clinical aspects. Immunol Rev. 86:47–70. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Louwen R and Hays JP: Is there an
unrecognised role for Campylobacter infections in (chronic)
inflammatory diseases? World J Clin Infect Dis. 3:58–69. 2013.
|
|
61
|
Ajene AN, Fischer Walker CL and Black RE:
Enteric pathogens and reactive arthritis: A systematic review of
Campylobacter, salmonella and Shigella-associated reactive
arthritis. J Health Popul Nutr. 31:299–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Durán-Avelar MJ, Vibanco-Pérez N,
Rodríguez-Ocampo AN, Peña-Virgen S and Zambrano-Zaragoza JF:
Lymphoproliferative response to the 30-kDa protein and a crude
lysate from Salmonella typhimurium in patients with ankylosing
spondylitis. Scand J Rheumatol. 42:232–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zambrano-Zaragoza JF, de Jesus
Durán-Avelar M, Rodríguez-Ocampo AN, García-Latorre E,
Burgos-Vargas R, Dominguez-Lopez ML, Pena-Virgen S and
Vibanco-Pérez N: The 30-kDa band from Salmonella typhimurium: IgM,
IgA and IgG antibody response in patients with ankylosing
spondylitis. Rheumatology (Oxford). 48:748–754. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Dominguez-López ML, Burgos-Vargas R,
Galicia-Serrano H, Bonilla-Sánchez MT, Rangel-Acosta HH,
Cancino-Diaz ME, Jiménez-Zamudio L, Granados J and García-Latorre
E: IgG antibodies to enterobacteria 60 kDa heat shock proteins in
the sera of HLA-B27 positive ankylosing spondylitis patients. Scand
J Rheumatol. 31:260–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lahesmaa R, Skurnik M and Toivanen P:
Molecular mimicry: Any role in the pathogenesis of
spondyloarthropathies? Immunol Res. 12:193–208. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Pacheco-Tena C, Alvarado De La Barrera C,
López-Vidal Y, Vázquez-Mellado J, Richaud-Patin Y, Amieva RI,
Llorente L, Martínez A, Zúñiga J, Cifuentes-Alvarado M and
Burgos-Vargas R: Bacterial DNA in synovial fluid cells of patients
with juvenile onset spondyloarthropathies. Rheumatology (Oxford).
40:920–927. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ekman P, Kirveskari J and Granfors K:
Modification of disease outcome in Salmonella-infected patients by
HLA-B27. Arthritis Rheum. 43:1527–1534. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ekman P, Saarinen M, He Q,
Gripenberg-Lerche C, Grönberg A, Arvilommi H and Granfors K:
HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected
(Salmonella nonpermissive) human monocytic U937 cells differ in
their production of cytokines. Infect Immun. 70:1609–1614. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Saarinen M, Ekman P, Ikeda M, Virtala M,
Grönberg A, Yu DT, Arvilommi H and Granfors K: Invasion of
Salmonella into human intestinal epithelial cells is modulated by
HLA-B27. Rheumatology (Oxford). 41:651–657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sartor RB: Importance of intestinal
mucosal immunity and luminal bacterial cell wall polymers in the
aetiology of inflammatory joint diseases. Baillieres Clin
Rheumatol. 3:223–245. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Salas-Cuestas F, Bautista-Molano W,
Bello-Gualtero JM, Arias I, Castillo DM, Chila-Moreno L,
Valle-Oñate R, Herrera D and Romero-Sánchez C: Higher levels of
secretory IgA are associated with low disease activity index in
patients with reactive arthritis and undifferentiated
spondyloarthritis. Front Immunol. 8:4762017. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Granfors K and Toivanen A:
IgA-anti-yersinia antibodies in yersinia triggered reactive
arthritis. Ann Rheum Dis. 45:561–565. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wendling D, Didier JM and Seilles E: Serum
secretory immunoglobulins in ankylosing spondylitis. Clin
Rheumatol. 15:590–593. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Franssen MJ, van de Putte LB and Gribnau
FW: IgA serum levels and disease activity in ankylosing
spondylitis: A prospective study. Ann Rheum Dis. 44:766–771. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cowling P, Ebringer R and Ebringer A:
Association of inflammation with raised serum IgA in ankylosing
spondylitis. Ann Rheum Dis. 39:545–549. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Rashid T, Wilson C and Ebringer A: The
link between ankylosing spondylitis, Crohn's disease, Klebsiella,
and starch consumption. Clin Dev Immunol. 2013:8726322013.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Eastmond CJ, Willshaw HE, Burgess SE,
Shinebaum R, Cooke EM and Wright V: Frequency of faecal Klebsiella
aerogenes in patients with ankylosing spondylitis and controls with
respect to individual features of the disease. Ann Rheum Dis.
39:118–123. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hunter T, Harding GK, Kaprove RE and
Schroeder ML: Fecal carriage of various Klebsiella and Enterobacter
species in patients with active ankylosing spondylitis. Arthritis
Rheum. 24:106–108. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ebringer A and Ghuloom M: Ankylosing
spondylitis, HLA-B27, and klebsiella: Cross reactivity and antibody
studies. Ann Rheum Dis. 45:703–704. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Puccetti A, Dolcino M, Tinazzi E, Moretta
F, D'Angelo S, Olivieri I and Lunardi C: Antibodies directed
against a peptide epitope of a klebsiella pneumoniae-derived
protein are present in ankylosing spondylitis. PLoS One.
12:e01710732017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Smith GW, Blackwell CC and Nuki G: Faecal
flora in spondyloarthropathy. Br J Rheumatol. 36:850–854. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Mäki-Ikola O, Penttinen M, Von Essen R,
Gripenberg-Lerche C, Isomäki H and Granfors K: IgM, IgG and IgA
class enterobacterial antibodies in serum and synovial fluid in
patients with ankylosing spondylitis and rheumatoid arthritis. Br J
Rheumatol. 36:1051–1053. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Mäki-Ikola O, Leirisalo-Repo M, Turunen U
and Granfors K: Association of gut inflammation with increased
serum IgA class Klebsiella antibody concentrations in patients with
axial ankylosing spondylitis (AS): Implication for different
aetiopathogenetic mechanisms for axial and peripheral AS? Ann Rheum
Dis. 56:180–183. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Shenkman L and Bottone EJ: Antibodies to
Yersinia enterocolitica in thyroid disease. Ann Intern Med.
85:735–739. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Benvenga S and Guarneri F: Molecular
mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord.
17:485–498. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Hansen PS, Wenzel BE, Brix TH and Hegedüs
L: Yersinia enterocolitica infection does not confer an increased
risk of thyroid antibodies: Evidence from a Danish twin study. Clin
Exp Immunol. 146:32–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Strieder TGA, . ‘The Amsterdam autoimmune
thyroid disease cohort’. https://dare.uva.nl/search?identifier=d4307adf-2a19-462f-8211-7922dcc988e0
|
|
88
|
Bliddal S, Nielsen CH and Feldt-Rasmussen
U: Recent advances in understanding autoimmune thyroid disease: The
tallest tree in the forest of polyautoimmunity. F1000res.
6:17762017. View Article : Google Scholar : PubMed/NCBI
|
